The FDA has said repeatedly that it's committed to fighting the opioid epidemic, and to that end, it approved BioDelivery Sciences' Bunavail Friday to treat dependence on the drugs.
written on 09.06.2014
The FDA has said repeatedly that it's committed to fighting the opioid epidemic, and to that end, it approved BioDelivery Sciences' Bunavail Friday to treat dependence on the drugs.
See our Cookie Privacy Policy Here